Key Events This Week
3 Aug: New 52-week and all-time high at Rs.518.45
4 Aug: New 52-week and all-time high at Rs.525
5 Aug: New 52-week and all-time high at Rs.561.15
7 Aug: New 52-week high at Rs.568 and all-time high close at Rs.564
Aug 07, 03:30 PM
BSE+NSE Vol: 1.86 lacs
3 Aug: New 52-week and all-time high at Rs.518.45
4 Aug: New 52-week and all-time high at Rs.525
5 Aug: New 52-week and all-time high at Rs.561.15
7 Aug: New 52-week high at Rs.568 and all-time high close at Rs.564

Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Surging past its previous peaks, Fermenta Biotech Ltd touched a fresh 52-week high of Rs 568 on 7 Aug 2026, marking a remarkable 63.21% gain over the past year. This milestone comes amid a backdrop of strong technical momentum that has propelled the stock well above its key moving averages, signalling robust price strength despite a broadly subdued market environment.
Read full news articleThe next results date for Fermenta Biotech Ltd is scheduled for August 11, 2026....
Read full news article
With a sustained five-day rally delivering a 22.38% gain, Fermenta Biotech Ltd surged to a fresh 52-week high of Rs 561.15 on 5 Aug 2026, marking a remarkable ascent from its 52-week low of Rs 256.40. This milestone underscores the stock’s robust price momentum amid a broadly positive market backdrop.
Read full news article
Fermenta Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, even as the stock continues to outperform the broader market significantly. With a current price of ₹546.75, close to its 52-week high of ₹551.25, the micro-cap pharmaceutical company’s price-to-earnings (P/E) ratio now stands at 24.22, reflecting a premium relative to its historical averages and many peers in the Pharmaceuticals & Biotechnology sector.
Read full news article
Surging to an intraday peak of Rs 525 on 4 Aug 2026, Fermenta Biotech Ltd has marked a significant milestone by hitting a fresh 52-week high. This achievement caps a four-day rally that has propelled the stock up by 15.74%, outpacing its sector and reflecting a strong technical momentum that has investors and analysts alike taking note.
Read full news article11 Aug 2026
Fermenta Biotech Ltd has declared 75% dividend, ex-date: 05 Aug 26
Fermenta Biotech Ltd has announced 5:5 stock split, ex-date: 08 Aug 18
Fermenta Biotech Ltd has announced 2:1 bonus issue, ex-date: 13 Feb 20
No Rights history available